Corey, Kristin, Joshua Helmkamp, Allan D. Kirk, Suresh Balu, David Thompson, Leila Mureebe, Joshua Watson, Keith Marsolo, Lesley Curtis, and Mark Sendak. “Assessing Quality of Real-World Data Supplied by an Automated Surgical Data Pipeline.” In Journal of the American College of Surgeons, 229:S89–S89. ELSEVIER SCIENCE INC, 2019.
Knechtle, Stuart J., Faouzi Saliba, Bjorn Nashan, El-Djouher Martzloff, Pascal Espie, Antonio Speziale, and Sandy Feng. “EFFICACY, SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ANTI-CD40 MONOCLONAL ANTIBODY ISCALIMAB (CFZ533) IN DE NOVO LIVER TRANSPLANT RECIPIENTS: RATIONALE AND DESIGN OF THE CONTRAIL I STUDY.” In Transplant International, 32:341–341. WILEY, 2019.
Loupy, Alexandre, Olivier Aubert, Babak J. Orandi, Maarten Naesens, Yassine Bouatou, Marc Raynaud, Gillian Divard, et al. “Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study.” Bmj 366 (September 17, 2019): l4923. https://doi.org/10.1136/bmj.l4923.
McElroy, L., and K. Sanders. “Abdominal Wall Function Following Ventral Incisional Hernia Repair: A Systematic Review.” In British Journal of Surgery, 106:79–80, 2019.
Al-Adra, David P., Maria Lambadaris, Andrew Barbas, Yanhong Li, Markus Selzner, Sunita K. Singh, Olusegun Famure, S Joseph Kim, and Anand Ghanekar. “Donor kidney volume measured by computed tomography is a strong predictor of recipient eGFR in living donor kidney transplantation.” World J Urol 37, no. 9 (September 2019): 1965–72. https://doi.org/10.1007/s00345-018-2595-x.
Brandman, Danielle, Hollis Lin, Anastasia McManus, Sonalee Agarwal, Larry M. Gache, William Irish, Jared Gollob, and Saša A. Živković. “Evaluating Prognostic Factors for Liver Transplantation Among United States Patients With Hereditary Transthyretin-Mediated (hATTR) Amyloidosis Using National Registry Data.” Prog Transplant 29, no. 3 (September 2019): 213–19. https://doi.org/10.1177/1526924819853832.
Callender, Carly J., Brian Iglehart, Serena J. Bagnasco, Maria P. Bettinotti, and Annette M. Jackson. “OR22 Use of donor-derived cell-free DNA (CFDNA) and donor-specific HLA antibody (DSA) testing as companion diagnostics following hla incompatible kidney transplantation.” In Human Immunology, 80:28–28. Elsevier BV, 2019. https://doi.org/10.1016/j.humimm.2019.07.024.